104 related articles for article (PubMed ID: 11206636)
21. Radiation therapy of esophageal cancer: role of high dose rate brachytherapy.
Sur RK; Singh DP; Sharma SC; Singh MT; Kochhar R; Negi PS; Sethi T; Patel F; Ayyagari S; Bhatia SP
Int J Radiat Oncol Biol Phys; 1992; 22(5):1043-6. PubMed ID: 1555950
[TBL] [Abstract][Full Text] [Related]
22. Influence of intraluminal brachytherapy dose on complications in the treatment of esophageal cancer.
Kumar MU; Swamy K; Supe SS; Anantha N
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1069-72. PubMed ID: 8262829
[TBL] [Abstract][Full Text] [Related]
23. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
[TBL] [Abstract][Full Text] [Related]
24. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
[TBL] [Abstract][Full Text] [Related]
25. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.
Taal BG; Aleman BM; Koning CC; Boot H
Br J Cancer; 1996 Nov; 74(9):1452-7. PubMed ID: 8912544
[TBL] [Abstract][Full Text] [Related]
26. Clinical results of radiation therapy for stage I esophageal cancer: a single institutional experience.
Shioyama Y; Nakamura K; Sasaki T; Ooga S; Urashima Y; Kimura M; Uehara S; Terashima H; Honda H
Am J Clin Oncol; 2005 Feb; 28(1):75-80. PubMed ID: 15685039
[TBL] [Abstract][Full Text] [Related]
27. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Coia LR; Engstrom PF; Paul A
J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
[TBL] [Abstract][Full Text] [Related]
28. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
Greene FL; Boulware RJ; Bianco J
Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemoradiotherapy for squamous cell carcinoma of thoracic esophagus: feasibility and outcome of large regional field and high-dose external beam boost irradiation.
Toita T; Ogawa K; Adachi G; Kakinohana Y; Nishikuramori Y; Iraha S; Utsunomiya T; Murayama S
Jpn J Clin Oncol; 2001 Aug; 31(8):375-81. PubMed ID: 11574630
[TBL] [Abstract][Full Text] [Related]
30. Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report.
Saito M; Yokoyama A; Kurita Y; Uematsu T; Tsukada H; Yamanoi T
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):673-80. PubMed ID: 10837951
[TBL] [Abstract][Full Text] [Related]
31. Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus.
Hareyama M; Nishio M; Kagami Y; Narimatsu N; Saito A; Sakurai T
Int J Radiat Oncol Biol Phys; 1992; 24(2):235-40. PubMed ID: 1526861
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
33. High dose rate intraluminal radiation in a combined modality treatment plan for carcinoma of the esophagus.
Peddada AV; Harvey JC; Anderson PJ; Davidson W; Smith DE; Kagan AR
J Surg Oncol; 1993 Mar; 52(3):160-3. PubMed ID: 8441272
[TBL] [Abstract][Full Text] [Related]
34. [Concurrent chemoradiotherapy for T4 and/or M1 LYM squamous cell carcinoma of the esophagus].
Miyata Y; Seki S; Ohtsu A; Kaneko K; Nakamura A
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1174-9. PubMed ID: 10945013
[TBL] [Abstract][Full Text] [Related]
35. Radiation therapy for the esophageal carcinoma: external irradiation versus high-dose rate intraluminal irradiation.
Chatani M; Matayoshi Y; Masaki N
Strahlenther Onkol; 1992 Jun; 168(6):328-32. PubMed ID: 1621210
[TBL] [Abstract][Full Text] [Related]
36. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
Ishikura S; Nihei K; Ohtsu A; Boku N; Hironaka S; Mera K; Muto M; Ogino T; Yoshida S
J Clin Oncol; 2003 Jul; 21(14):2697-702. PubMed ID: 12860946
[TBL] [Abstract][Full Text] [Related]
37. [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].
Lin Q; Gao XS; Qiao XY; Chen K; Wang YD; Zhou ZG
Ai Zheng; 2008 Oct; 27(10):1077-81. PubMed ID: 18851788
[TBL] [Abstract][Full Text] [Related]
38. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
[TBL] [Abstract][Full Text] [Related]
39. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
40. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA.
Gaspar LE; Nag S; Herskovic A; Mantravadi R; Speiser B
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):127-32. PubMed ID: 9212013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
